Idorsia Ltd. (IDRSF)
5.38
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Idorsia Free Cash Flow : -172.44M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -172.44M |
| March 31, 2026 | -190.16M |
| December 31, 2025 | -228.56M |
| September 30, 2025 | -178.49M |
| June 30, 2025 | -261.89M |
| March 31, 2025 | -321.98M |
| December 31, 2024 | -383.70M |
| September 30, 2024 | -501.87M |
| June 30, 2024 | -475.03M |
| March 31, 2024 | -567.70M |
| December 31, 2023 | -705.66M |
| September 30, 2023 | -812.52M |
| June 30, 2023 | -932.03M |
| March 31, 2023 | -932.11M |
| December 31, 2022 | -929.69M |
| September 30, 2022 | -920.10M |
| June 30, 2022 | -845.05M |
| March 31, 2022 | -781.96M |
| Date | Value |
|---|---|
| December 31, 2021 | -678.77M |
| September 30, 2021 | -595.93M |
| June 30, 2021 | -564.65M |
| March 31, 2021 | -457.95M |
| December 31, 2020 | -400.86M |
| September 30, 2020 | -393.48M |
| June 30, 2020 | -425.49M |
| March 31, 2020 | -484.53M |
| December 31, 2019 | -484.31M |
| September 30, 2019 | -481.33M |
| June 30, 2019 | -446.69M |
| March 31, 2019 | -407.88M |
| December 31, 2018 | -374.19M |
| September 30, 2018 | -102.99M |
| June 30, 2018 | -61.72M |
| March 31, 2018 | 112.34M |
| December 31, 2017 | 89.56M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Basilea Pharmaceutica AG | 71.34M |
| Santhera Pharmaceuticals Holding AG | -0.8494M |
| BeOne Medicines Ltd. | 1.333B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -371.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -43.01M |
| Cash from Investing (Quarterly) | -3.521M |
| Cash from Financing (Quarterly) | 38.69M |
| Free Cash Flow Per Share (Quarterly) | -0.1818 |
| Free Cash Flow to Equity (Quarterly) | -41.35M |
| Free Cash Flow to Firm (Quarterly) | -18.59M |
| Free Cash Flow Yield | -13.20% |